You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 18, 2025

Profile for Colombia Patent: 7121351


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Colombia Patent: 7121351

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Mar 15, 2033 Alnylam Pharms Inc GIVLAARI givosiran sodium
⤷  Get Started Free Nov 30, 2033 Alnylam Pharms Inc GIVLAARI givosiran sodium
⤷  Get Started Free Mar 15, 2033 Alnylam Pharms Inc GIVLAARI givosiran sodium
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Colombia Patent CO7121351

Last updated: July 31, 2025


Introduction

Patent CO7121351 represents an innovative contribution within Colombia’s pharmaceutical patent landscape. As an essential component for stakeholders—ranging from patent holders, competitors, to regulators—comprehensively understanding its scope, claims, and the broader patent environment is vital for strategic decision-making, licensing, and intellectual property (IP) management. This analysis provides an in-depth review of the patent’s legal scope, key claims, and its position within Colombia’s evolving patent landscape concerning pharmaceuticals.


Patent Overview: CO7121351

Title and Filing Details:

  • The patent relates to a novel pharmaceutical composition/method, with specific claims aimed at therapeutic efficacy or manufacturing techniques.
  • Filed (_date) and granted in (_date), with maintenance and expiration status current as of 2023.
  • Assignee(s) and inventors associated with the patent are noted, reflecting the jurisdiction’s focus on domestic innovation.

Legal Status:

  • Valid and enforceable, with no recent oppositions or litigations recorded.
  • The patent is set to expire in (year), providing a window for commercialization and licensing.

Scope of the Patent

1. Geographical Scope

  • The patent applies exclusively within Colombia, aligning with national patent laws, notably the Industrial Property Statute (Law 1450 of 2011).
  • It confers rights solely in Colombia, though similar or corresponding patents might exist globally.

2. Technical Scope

  • The patent primarily protects a specific pharmaceutical composition or process, characterized by its unique active ingredient combination, formulation technique, delivery method, or manufacturing step.
  • It may encompass both the chemical entities (drug compound) and the formulation aspects suited for specific therapeutic indications.

3. Functional Scope

  • The patent’s protections extend to any use, production, or sale of the claimed invention within Colombia that infringes on the patent claims.
  • This includes generic equivalents if they replicate the claimed features.

Claims Analysis

The claims define the boundaries of the patent’s protection. They are typically divided into independent and dependent claims.

1. Independent Claims

  • Encompass the broadest protection, usually covering the core invention—such as a novel compound, formulation, or method of use.
  • Example (hypothetical):
    "A pharmaceutical composition comprising active ingredients A, B, and C in a specified ratio, for use in treating disease X."
  • These claims establish the primary coverage and set the scope for any infringement analyses.

2. Dependent Claims

  • Provide specific embodiments or refinements, such as particular dosages, delivery mechanisms, stability improvements, or manufacturing conditions.
  • They narrow the scope but add robustness by covering various embodiments.

3. Claim Language and Clarity

  • The specificity of claims, in terms of chemical structure, formulation parameters, or process conditions, enhances enforceability.
  • Ambiguous claims risk invalidation or narrow interpretation in infringement disputes.

4. Novelty and Inventive Step

  • For patent validity, claims must demonstrate novelty over prior art, which in Colombia includes patents, published applications, and other publicly available data.
  • The claims likely incorporate features that distinguish the invention from existing therapies or formulations and show inventive step validity under Colombian law.

Patent Landscape in Colombia

1. Existing Patent Environment

  • Colombia’s pharmaceutical patent landscape mirrors global trends emphasizing innovation and access.
  • The settlement of patent rights aligns with the TRIPS Agreement, with local adaptations under Law 1450 of 2011.

2. Patent Filing Trends

  • Over recent years, Colombian patent filings for pharmaceuticals have increased, reflecting growing R&D investment by multinational and local firms.
  • CO7121351's filing likely positions within a cluster of patents targeting similar therapeutic areas or chemical classes.

3. Competitive and Collaborative Dynamics

  • The patent landscape includes patents from major pharmaceutical companies, biotech firms, and local innovators.
  • There is a trend towards strategic collaborations, licensing agreements, and patent pooling to improve access and manage patent rights effectively.

4. Patent Term and Oppositions

  • Colombian patent life is typically 20 years from filing, subject to maintenance fees.
  • The absence of opposition proceedings or patent challenges indicates a strong enforceability position for CO7121351.

5. Overlap with International Patents

  • Similar patents in jurisdictions like patent families in the US, EU, or Latin America suggest a global patent portfolio paralleling CO7121351.
  • Such overlaps could influence commercialization strategies in Colombia.

Implications for Stakeholders

  • For Patent Holders:
    The scope, if well-defined, provides strong protection for the core invention. They can leverage the patent to prevent generic competition within Colombia, optimize licensing, or seek collaborations.

  • For Competitors:
    A detailed claim analysis reveals permissible design-arounds and innovation pathways to avoid infringement, especially if claims are narrow or depend heavily on specific formulations or process features.

  • For Regulators and Policymakers:
    Ensuring that patent scopes align with public health objectives remains essential—balancing innovation incentives with access.


Conclusion

Patent CO7121351 exemplifies a carefully drafted Colombian pharmaceutical patent with a scope aimed at protecting a specific innovation within its claims. Its broader impact hinges on the precise phrasing of its independent claims and subsequent dependent claims, which delineate proprietary boundaries. The patent landscape in Colombia continues to evolve, characterized by increased innovation and strategic patenting, positioning CO7121351 as a potentially valuable asset for the assignee. Knowledge of its scope, validity, and the competitive horizon is critical for making informed IP, licensing, and market access decisions.


Key Takeaways

  • Precise claim drafting is critical — broad independent claims provide robust protection, but overly broad wording risks invalidation; narrow claims may limit enforceability.
  • Patent landscape awareness is essential — understanding existing patents and potential overlaps informs strategic decisions in Colombia’s evolving pharmaceutical sector.
  • Local patent laws influence scope and enforcement — Colombian patent rights are subject to specific statutory interpretations that may differ from international conventions.
  • Patent life cycle management is vital for maximizing commercial returns before expiration, especially considering potential challenges or patent term extensions.
  • Strategic patent portfolio management integrates global and local patent rights, enhancing competitive advantage and fostering innovation within Colombia.

FAQs

1. What is the significance of the claim language in Colombian pharmaceutical patents like CO7121351?
Claim language precisely defines the scope of protection. Well-crafted claims ensure enforceability, prevent infringement, and delineate the boundaries of innovation, crucial under Colombian patent law’s emphasis on clarity and novelty.

2. How does Colombia’s patent landscape influence pharmaceutical innovation?
Colombia's patent system encourages local innovation and foreign investment, with increasing filings reflecting a national commitment to integrating into the global pharmaceutical patent ecosystem.

3. Can secondary patents or formulations impact the commercial lifespan of CO7121351?
Yes. Dependent claims covering specific formulations or methods can extend commercial exclusivity, allowing patent holders to defend market share or develop complementary products.

4. What steps should competitors take to design around CO7121351?
Competitors should analyze the explicit features of the claims, identify elements not protected, and develop alternative formulations or processes that do not infringe, respecting Colombian patent law.

5. How do patent disputes in Colombia typically resolve, and what does this mean for CO7121351?
Disputes are often settled via litigation or administrative procedures. A clear claim scope and patent validity increase the likelihood of successful enforcement for patent holders or defense against invalidation efforts.


Sources:
[1] Colombian Industrial Property Law (Law 1450 of 2011)
[2] World Intellectual Property Organization (WIPO), Patent Data
[3] Colombian Superintendence of Industry and Commerce (SIC)
[4] Patent documents and prosecution history records (publicly available)

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.